2007

     March        First patient in phase II for XY2405
     January     Dr. Vincent F. Simmon President, CEO
     January     Xytis announces $40 million NIH grant
     January     Xytis begins Phase II for XY2405 in TBI

2006
     January     Xytis merges and raises $24.5M

2005

     January     Xytis Licenses XY 2401 from Rotta
     June         Xytis Licenses XY 2405 from Fournier
     November  Xytis starts Phase I for XY 2401 in SZ